Speaker Profile
Global Head, Commercial Precision Medicine Strategy, Johnson & Johnson
Biography
Neha Kumar is passionate about transforming healthcare, and has a 15+ year track record of building organizations that launch innovative healthcare products and drive change across the healthcare ecosystem. She currently leads Global Commercial Strategy for Precision Medicine at JJ, focusing on precision medicine beyond oncology. Prior to JJ, Neha founded a consulting firm supporting startups in genomics, digital health, and health data. Before that, Neha was VP New Markets and Commercial at Invitae, and VP of Global Marketing at CooperSurgical. She joined CooperSurgical following the acquisition of Recombine, where she was Chief Product Officer and founding employee.
Talk
A New Era: Precision Medicine in Women's Health
It's time for precision medicine in women's health - starting with alloimmune disorders of pregnancy, HDFN and FNAIT. How can we bring together advanced diagnostics with therapeutic innovation to bring about an era of precision medicine in women's health?
Clinical Dx Showcase:
JnJ
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
